Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H).
(Q42718412)
scientific article published on June 2006
scientific article published on June 2006
Language:
Current Data About
Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H).